Lorlatinib in patients with ALK-positive non-small-cell lung cancer: results from a global phase 2 study
Journal
The Lancet Oncology
Journal Volume
19
Journal Issue
12
Pages
1654-1667
Date Issued
2018
Author(s)
Solomon B.J.
Besse B.
Bauer T.M.
Felip E.
Soo R.A.
Camidge D.R.
Chiari R.
Bearz A.
Gadgeel S.M.
Riely G.J.
Tan E.H.
Seto T.
James L.P.
Clancy J.S.
Abbattista A.
Martini J.-F.
Chen J.
Peltz G.
Thurm H.
Ignatius Ou S.-H.
Shaw A.T.
SDGs
Publisher
Lancet Publishing Group
Type
journal article